Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors

Advances in Anatomic Pathology

Volumn 8, Issue 5, 2001, Pages 273-275

  Chang, Karen L ^a   Folpe, Andrew L ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clear cell sarcoma; Diagnosis; Immunohistochemistry; Malignant melanoma; Microphthalmia transcription factor; Monoclonal antibodies; Perivascular epithelioid cell

Indexed keywords

DIAGNOSTIC AGENT; DNA BINDING PROTEIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MITF PROTEIN, HUMAN; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR;

HUMAN; IMMUNOLOGY; MELANOMA; PATHOLOGY; REVIEW; SKIN TUMOR;

ANTIBODIES, MONOCLONAL; DNA-BINDING PROTEINS; HUMANS; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; SKIN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0035462972     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200109000-00004     Document Type: Article

References (23)

1. American Cancer Society. Cancer facts & figures-1997. Atlanta, GA: American Cancer Society, 1997.
2. Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle cell malignant melanoma: an immunohistochemical study. Am J Surg Pathol 1996;20:1489-500. (Pubitemid 26411717)
3. Carreira S, Liu B, Goding CR. The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes. J Biol Chem 2000;275:21920-7. (Pubitemid 30621764)
4. Udono T, Yasumoto K, Takeda K, et al. Structural organization of the human microphthalmia-associated transcription factor gene containing four alternative promoters. Biochim Biophys Acta 2000;1491:205-19. (Pubitemid 30173345)
5. Verastegui C, Bille K, Ortonne JP, et al. Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J Biol Chem 2000;275:30757-60.
6. Kawaguchi N, Noda M. Mitf is expressed in osteoclast progenitors in vitro. Exp Cell Res 2000;260:284-91.
7. King R, Weilbaecher KN, McGill G, et al. Microphthalmia transcription factor: a sensitive and specific melanocyte marker for melanoma diagnosis. Am J Pathol 1999;155:731-8. (Pubitemid 29426819)
8. Koch MB, Shih IM,Weiss SW, et al. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics. Am J Surg Pathol 2001;25:58-64. (Pubitemid 32001833)
9. King R, Googe PB, Weilbaecher KN, et al. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol 2001;25:51-7. (Pubitemid 32001832)
10. Busam KJ, Iversen K, Coplan KC, et al. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol 2001;25:197-204. (Pubitemid 32167501)
11. Miettinen M, Fernandez M, Franssila K, et al. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers. Am J Surg Pathol 2001;25:205-11. (Pubitemid 32167502)
12. Bacchi CE, Bonetti F, Pea M, et al. HMB-45: a review. Appl Immunohistochem 1996;4:73-85. (Pubitemid 126481824)
13. Kaufmann O, Koch S, Burghardt J, et al. Tyrosinase, Melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections. Mod Pathol 1998;11:740-6. (Pubitemid 28381608)
14. Busam KJ, Jungbluth AA. Melan-A, a new melanocytic differentiation marker. Adv Anat Pathol 1999;6:12-8.
15. Zavala-Pompa A, Folpe AL, Jimenez RE, et al. Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic markers. Am J Surg Pathol 2001;25:65-70. (Pubitemid 32001834)
16. Folpe AL, Goodman ZD, Ishak KG, et al. Clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres: a novel member of the perivascular epithelioid clear cell family of tumors with a predilection for children and young adults. Am J Surg Pathol 2000;24:1239-46.
17. Bonetti F, Pea M, Martignoni G, et al. Clear cell ("sugar") tumor of the lung is a lesion strictly related to angiomyolipoma: the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology 1994;26:230-6.
18. Martignoni G, Pea M, Bonetti F, et al. Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study. Am J Surg Pathol 1998;22:663-72. (Pubitemid 28280268)
19. Pea M, Martignoni G, Zamboni G, et al. Perivascular epithelioid cell [letter; comment]. Am J Surg Pathol 1996;20:1149-53.
20. Pea M, Martignoni G, Bonetti F, et al. Tumors characterized by the presence of HMB45-positive perivascular epithelioid cell (PEC): a novel entity in surgical pathology. Electron J Pathol Histol 1997;3:28-40. (Pubitemid 29221501)
21. Zamboni G, Pea M, Martignoni G, et al. Clear cell "sugar" tumor of the pancreas: a novel member of the family of lesions characterized by the presence of perivascular epithelioid cells. Am J Surg Pathol 1996;20:722-30.
22. Jungbluth AA, King R, Fisher DE, et al. Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas. Appl Immunohistochem Molecul Morphol 2001;9:29-34. (Pubitemid 32179107)
23. Granter SR, Weilbaecher KN, Quigley C, et al. Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation. Mod Pathol 2001;14:6-9. (Pubitemid 32098804)